Omeros | OMER - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Adma Biologics USD 2.15B 2.19B 2026-03
Alnylam Pharmaceuticals USD 40.19B 3.96B 2026-06
BioMarin Pharmaceutical USD 11.71B 651M 2026-08
Cytokinetics USD 9.6B 1.95B 2026-08
Gilead Sciences USD 168.68B 11.82B 2026-08
Heron Therapeutics USD 238M 7M 2025-12
Immunic USD 64M 23M 2025-12
Insmed USD 19.68B 3.43B 2026-08
MacroGenics USD 184M 82M 2026-03
Pacira USD 1.28B 286M 2026-08
Pfizer USD 153.17B 14.73B 2026-08
Sarepta Therapeutics USD 1.5B 402M 2026-08
United Therapeutics USD 24.42B 1.42B 2026-08
Vertex Pharmaceuticals USD 137.33B 11.26B 2026-08